[Endocannabinoids receptor blocker lets tumble not only money. A drug against metabolic syndrome?]. [electronic resource]
Producer: 20050214Description: 12 p. digitalISSN:- 1438-3276
- Bradykinin -- antagonists & inhibitors
- Cannabinoid Receptor Antagonists
- Cannabinoids -- antagonists & inhibitors
- Clinical Trials, Phase III as Topic
- Double-Blind Method
- Humans
- Metabolic Syndrome -- drug therapy
- Piperidines -- administration & dosage
- Placebos
- Pyrazoles -- administration & dosage
- Randomized Controlled Trials as Topic
- Rimonabant
- Time Factors
- Weight Loss
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.